Cargando…

IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells

Detalles Bibliográficos
Autores principales: Dong, E, Yue, Xiao-zhu, Shui, Lin, Liu, Bin-rui, Li, Qi-qi, Yang, Yun, Luo, Hui, Wang, Wei, Yang, Han-shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811529/
https://www.ncbi.nlm.nih.gov/pubmed/33454722
http://dx.doi.org/10.1038/s41392-020-00357-7
_version_ 1783637518774697984
author Dong, E
Yue, Xiao-zhu
Shui, Lin
Liu, Bin-rui
Li, Qi-qi
Yang, Yun
Luo, Hui
Wang, Wei
Yang, Han-shuo
author_facet Dong, E
Yue, Xiao-zhu
Shui, Lin
Liu, Bin-rui
Li, Qi-qi
Yang, Yun
Luo, Hui
Wang, Wei
Yang, Han-shuo
author_sort Dong, E
collection PubMed
description
format Online
Article
Text
id pubmed-7811529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78115292021-01-25 IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells Dong, E Yue, Xiao-zhu Shui, Lin Liu, Bin-rui Li, Qi-qi Yang, Yun Luo, Hui Wang, Wei Yang, Han-shuo Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-01-07 /pmc/articles/PMC7811529/ /pubmed/33454722 http://dx.doi.org/10.1038/s41392-020-00357-7 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Dong, E
Yue, Xiao-zhu
Shui, Lin
Liu, Bin-rui
Li, Qi-qi
Yang, Yun
Luo, Hui
Wang, Wei
Yang, Han-shuo
IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
title IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
title_full IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
title_fullStr IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
title_full_unstemmed IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
title_short IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
title_sort ifn-γ surmounts pd-l1/pd1 inhibition to car-t cell therapy by upregulating icam-1 on tumor cells
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811529/
https://www.ncbi.nlm.nih.gov/pubmed/33454722
http://dx.doi.org/10.1038/s41392-020-00357-7
work_keys_str_mv AT donge ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT yuexiaozhu ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT shuilin ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT liubinrui ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT liqiqi ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT yangyun ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT luohui ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT wangwei ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells
AT yanghanshuo ifngsurmountspdl1pd1inhibitiontocartcelltherapybyupregulatingicam1ontumorcells